CAMBRIDGE, Mass. (AP) _ Infinity Pharmaceuticals Inc. (INFI) on Tuesday reported a loss of $22.9 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had a loss of 46 cents per share.
For the year, the company reported that its loss narrowed to $30.1 million, or 61 cents per share. Revenue was reported as $18.7 million.
In the final minutes of trading on Tuesday, the company's shares hit $2.95. A year ago, they were trading at $6.62.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INFI at https://www.zacks.com/ap/INFI
Keywords: Infinity Pharmaceuticals, Earnings Report